Impact of increased adiposity on extended aromatase inhibitor treatment in postmenopausal patients with estrogen receptor positive (ER plus ) breast cancer: a retrospective analysis of the SOLE trial

被引：0
|
作者：
Isnaldi, Edoardo
Richard, Francois
Marano, Giuseppe
Boracchi, Patrizia
Maetens, Marion
Floris, Giuseppe
Jerusalem, Guy
Gombos, Andrea
Thompson, Alastair M.
Stefan, Erika Hitre
Colleoni, Marco
Dell'Orto, Patrizia
Kammler, Roswitha
Neven, Patrick
Viale, Giuseppe
Regan, Meredith
Biganzoli, Elia
Desmedt, Christine
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P3-05-28
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-05-28
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Erratum to: A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure
    Suleiman Massarweh
    Edward Romond
    Esther P. Black
    Emily Van Meter
    Brent Shelton
    Vera Kadamyan-Melkumian
    Mark Stevens
    Richard Elledge
    Breast Cancer Research and Treatment, 2015, 149 : 565 - 565
  • [32] Evaluation of biomarker association with efficacy for abiraterone acetate (AA) plus prednisone (P) with or without exemestane (E) in postmenopausal patients (pts) with estrogen receptor-positive (ER plus ) metastatic breast cancer (mBCa) progressing after a nonsteroidal aromatase inhibitor (NSAI).
    Li, Weimin
    O'Shaughnessy, Joyce
    Ricci, Deborah Sokol
    Griffin, Thomas W.
    Kheoh, Thian San
    Yu, Margaret K.
    Gormley, Michael
    Martin, Jason L.
    Schaffer, Michael
    Zelinsky, Kathy
    Hayes, Daniel F.
    Campone, Mario
    Bondarenko, Igor
    Zbarskaya, Irma
    Brain, Etienne
    Stenina, Marina B.
    Ivanova, Olga
    Graas, Marie-Pascale
    Neven, Patrick
    Johnston, Stephen R. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] A phase II study of combined fulvestrant and everolimus in metastatic estrogen receptor (ER) plus breast cancer after aromatase inhibitor (AI) failure
    Massarweh, Suleiman Alfred
    Romond, Edward H.
    Croley, Jessica Jones
    Black, Esther P.
    Chambers, Mara D.
    Stevens, Mark
    Shelton, Brent
    Kadamyan, Vera
    Elledge, Richard M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer
    Rowan T. Chlebowski
    Breast Cancer Research and Treatment, 2008, 112 : 25 - 34
  • [35] Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer
    Chlebowski, Rowan T.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 112 (Suppl 1) : 25 - 34
  • [36] Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index
    Sendur, M. A. N.
    Aksoy, S.
    Zengin, N.
    Altundag, K.
    BRITISH JOURNAL OF CANCER, 2012, 107 (11) : 1815 - 1819
  • [37] Retrospective Analysis of Concurrent vs. Sequential Administration of Radiotherapy and Hormone Therapy Using Aromatase Inhibitor for Hormone Receptor-positive Postmenopausal Breast Cancer
    Ishitobi, Makoto
    Komoike, Yoshifumi
    Motomura, Kazuyoshi
    Koyama, Hiroki
    Nishiyama, Kinji
    Inaji, Hideo
    ANTICANCER RESEARCH, 2009, 29 (11) : 4791 - 4794
  • [38] Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index
    M A N Sendur
    S Aksoy
    N Zengin
    K Altundag
    British Journal of Cancer, 2012, 107 : 1815 - 1819
  • [39] Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients (vol 18, 651, 2018)
    Venturelli, Elisabetta
    Orenti, Annalisa
    Fabricio, Aline S. C.
    Garrone, Giulia
    Agresti, Roberto
    Paolini, Biagio
    Bonini, Chiara
    Gion, Massimo
    Berrino, Franco
    Desmedt, Christine
    Coradini, Danila
    Biganzoli, Elia
    BMC CANCER, 2018, 18
  • [40] Accumulation of p53 is prognostic for aromatase inhibitor resistance in early-stage postmenopausal patients with ER-positive breast cancer
    Jia, Xiao-qing
    Hong, Qi
    Cheng, Jing-yi
    Li, Jian-wei
    Wang, Yu-jie
    Mo, Miao
    Shao, Zhi-min
    Shen, Zhen-zhou
    Liu, Guang-yu
    ONCOTARGETS AND THERAPY, 2015, 8 : 549 - 555
12345